Obesity Medicine Association

#ObesityCareWeek is the time to increase our understanding of obesity and the stigma attached. It’s past time to #StopWeightBias. Visit obesitycareweek.org to learn more and take action today!

Early Bird Pricing Ends Friday! Time is running out to save on Obesity Medicine 2025! Join us in National Harbor, MD, from April 23-27 for this one-of-a-kind annual conference. Register by this Friday, March 7, to save up to $300! Don't miss your chance to enhance your expertise and network with top professionals. Register today at https://bit.ly/4igwUYV #ObesityMedicine2025 #OM25 #Obesity

Today, we recognize World Obesity Day.????Obesity is a complex, chronic disease that requires evidence-based care and a multidisciplinary approach. The OMA is dedicated to supporting healthcare professionals with the latest research, education, and resources to improve obesity treatment and patient outcomes. In support of World Obesity Day, explore open-access obesity research from Elsevier at https://bit.ly/3Quou4i #WorldObesityDay #ObesityCareWeek #TreatObesity #ObesityMedicine #OM

Stigma-free, evidence-based obesity care matters. How will you #CommitToCare? Get information, find resources, and take action during Obesity Care Week 2025, March 3-7! Visit obesitycareweek.org to learn more and sign up for alerts. #OCW

GLP-1s: The 20-Year "Overnight Success" Many people think GLP-1 medications are brand new, but they’ve actually been on the market since 2005. So why are they suddenly the hottest topic in weight loss and diabetes care? The answer lies in three major breakthroughs that changed everything: ?? 1. More Potent & Effective – Early GLP-1s weren’t nearly as powerful as they are today. The newer versions have dramatically improved results for both blood sugar control and weight loss. ?? 2. Easier Administration – In the beginning, GLP-1s required twice-daily injections. Then came once-daily options. Today, the most effective versions require just one injection per week, making them far more convenient. ? 3. FDA Approval for Weight Loss – Originally approved for type 2 diabetes, GLP-1s gained FDA approval for weight management, significantly expanding their use and popularity. These advancements explain why GLP-1s have gone from a niche diabetes treatment to a mainstream medical breakthrough that’s helping millions worldwide. The science keeps evolving, and so do the possibilities! #GLP1 #WeightLoss #DiabetesCare #HealthInnovation #WellnessRevolution

Early Bird Pricing Ends Soon! Don't forget to register for Obesity Medicine 2025, taking place in National Harbor, MD, from April 23-27. Gain cutting-edge insights, connect with fellow obesity medicine experts, and stay ahead in evidence-based obesity treatment. Don’t miss this opportunity to enhance your knowledge and network with top professionals in the field. Register by March 7 to save up to $300! Secure your spot today at https://bit.ly/4igwUYV #ObesityMedicine2025 #OM25 #Obesity

In honor of Obesity Care Week 2025, join us for a FREE live webinar on incorporating obesity advocacy into your practice. Taking place on March 6, the webinar will explore how clinicians can integrate advocacy into their daily work to improve patient care and drive meaningful change in obesity treatment. Don’t miss this opportunity to hear from Dr. Leslie Golden and elevate your role in obesity care advocacy. Register now at https://bit.ly/43ckAUW #CommitToCare #ObesityAdvocacy #ObesityMedicine #OCW

#IAmOMA ???? We’re excited to launch our I Am OMA video series, where members share their personal experiences and what being part of the OMA means to them. Today, we’re featuring Dr. Britta Reierson, who shares how her OMA membership has impacted her journey. Stay tuned for more inspiring testimonials from your fellow OMA members. #OMA #OMAMembers #ObesityMedicine

The Trump Administration has the opportunity to address obesity and treat it. In a recent Obesity Care Advocacy Network (OCAN) survey, an overwhelming majority of Americans reported that they support extending coverage to obesity treatments under Medicaid. Find out why 71% of Americans support the finalization of the proposed policy. See the polling results: https://bit.ly/3XbHJDl #Obesity #ObesityMedicine

The OMA Pediatric Committee provides monthly updates on groundbreaking research in obesity care. This month, they highlight the critical connection between childhood obesity and cardiovascular risk—shedding light on how early intervention can improve long-term heart health. Read the full article at https://bit.ly/41ltbna #PediatricObesity #ObesityMedicine #CardiovascularRisk